Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG recombinant human growth hormone in children with idiopathic short stature (Phase II)
CTR20160674Phase 2Completed
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Start
- Sep 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of genotropin miniquick in Idiopathic Short Stature (ISS), sponsored by Changchun GeneScience Pharmaceutical Co., Ltd.. Started Sep 2016; status: completed.
02
Drugs
genotropin miniquick
03
Conditions
Idiopathic Short Stature (ISS)
Beyond the preview
Go deeper on CTR20160674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160674.